Cointime

Varigen

company

About

Varigen Biosciences is developing new technologies for capturing and expressing natural product pathways.

  • 1 - 10

Highlights

Total Funding Amount
$225K
Funding Rounds
2
Investors
2

Details

Last Funding Type
Non-Equity Assistant
Industries
Bioinformatics,Biotechnology,Environmental Engineering,Genetics,Life Science
Founded date
Jan 1, 2016
Number Of Employee
1 - 10
Operating Status
Active

Varigen Biosciences is developing new technologies for capturing and expressing natural product pathways. Learn about our DNAtrap™ custom cloning service which delivers verified clones of your DNA target (up to 100 kb) in just 10 days at http://varigenbiosciences.com/dnatrap-custom-cloning-service/. Learn about how our BigDNA™ metagenomics libraries can revolutionize natural product discovery at http://varigenbiosciences.com/products/.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
$225K
Varigen has raised a total of $225K in funding over 2 rounds. Their latest funding was raised on Jan 1, 2021 from a Non-Equity Assistant round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jan 1, 2021 Non-Equity Assistant — 1 — — Detail
Dec 11, 2016 Grant $225K 1 National Science Foundation — Detail

Investors

Number of Lead Investors
Number of Investors
1
2
Varigen is funded by 2 investors. National Science Foundation and Newchip are the most recent investors.
Investor Name Lead Investor Funding Round
National Science Foundation Yes Grant
Newchip — Non-Equity Assistant
Cointime
เนื้อหา
บริษัท